Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2023 Nov 16:2023.11.14.567135.
doi: 10.1101/2023.11.14.567135.

Pathogenicity Prediction of GABAA Receptor Missense Variants

Affiliations

Pathogenicity Prediction of GABAA Receptor Missense Variants

Ya-Juan Wang et al. bioRxiv. .

Abstract

Variants in the genes encoding the subunits of gamma-aminobutyric acid type A (GABAA) receptors are associated with epilepsy. To date, over 1000 clinical variants have been identified in these genes. However, the majority of these variants lack functional studies and their clinical significance is uncertain although accumulating evidence indicates that proteostasis deficiency is the major disease-causing mechanism for GABAA receptor variants. Here, we apply two state-of-the-art modeling tools, namely AlphaMissense, which uses an artificial intelligence-based approach based on AlphaFold structures, and Rhapsody, which integrates sequence evolution and known structure-based data, to predict the pathogenicity of saturating missense variants in genes that encode the major subunits of GABAA receptors in the central nervous system, including GABRA1, GABRB2, GABRB3, and GABRG2. Our results demonstrate that the predicted pathogenicity correlates well between AlphaMissense and Rhapsody although AlphaMissense tends to generate higher pathogenic probability. Furthermore, almost all annotated pathogenic variants in the ClinVar clinical database are successfully identified from the prediction, whereas uncertain variants from ClinVar partially due to the lack of experimental data are differentiated into different pathogenicity groups. The pathogenicity prediction of GABAA receptor missense variants provides a resource to the community as well as guidance for future experimental and clinical investigations.

Keywords: Epilepsy; GABAA receptors; Ion channels; pathogenicity; proteostasis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Structures and sequence alignment of GABAA receptors.
(A) Cartoon representation of pentameric α1βγ2 receptors, built from 6X3S.pdb. The principal side of one subunit is denoted as “+”, whereas the complementary side of one subunit is denoted as “−”. (B) The schematic of the primary protein sequence of a GABAA receptor subunit. NTD, N-terminal domain; M1-M4, transmembrane helices 1 to 4. (C) The secondary structures of a GABAA receptor subunit. The two cysteines in the signature Cys-loop are colored in yellow. (D) The sequence alignment of major human GABAA receptor subunits, including α1, β2, β3, and γ2. The residue positions that harbor clinical missense variants are highlighted. According to ClinVar annotation, pathogenic variants are colored in red, uncertain in yellow, and benign in green.
Figure 2.
Figure 2.. Pathogenicity prediction of GABAA receptor α1 subunit, GABRA1.
(A) Positions of clinical missense variants are displayed in the three-dimensional structure of α1 subunit, built from 6X3S.pdb using PyMOL. According to ClinVar annotation, Class I pathogenic variants are colored in red, Class II uncertain variants in yellow, and Class III benign variants in green. (B) Pathogenicity prediction of saturating substitutions of GABRA1. Heat maps display the pathogenic probability of selected key regions. The top picture is from Rhapsody (RS) prediction, whereas the bottom picture is from AlphaMissense (AM) prediction. Wild type amino acids were colored in yellow for RS, and black for AM. (C) Correlation between Rhapsody and AlphaMissense prediction. Red dots represent pathogenic variants, yellow dots represent uncertain variants, and green dots represent benign variants according to ClinVar annotation. If no predictions are available in Rhapsody, such variants are artificially assigned a value of zero for Rhapsody probability.
Figure 3.
Figure 3.. Pathogenicity prediction of GABAA receptor β2 subunit, GABRB2.
(A) Positions of clinical missense variants are displayed in the three-dimensional structure of β2 subunit, built from 6X3S.pdb using PyMOL. According to ClinVar annotation, Class I pathogenic variants are colored in red, Class II uncertain variants in yellow, and Class III benign variants in green. (B) Pathogenicity prediction of saturating substitutions of GABRB2. Heat maps display the pathogenic probability of selected key regions. The top picture is from Rhapsody (RS) prediction, whereas the bottom picture is from AlphaMissense (AM) prediction. Wild type amino acids were colored in yellow for RS, and black for AM. (C) Correlation between Rhapsody and AlphaMissense prediction. Red dots represent pathogenic variants, yellow dots represent uncertain variants, and green dots represent benign variants according to ClinVar annotation. If no predictions are available in Rhapsody, such variants are artificially assigned a value of zero for Rhapsody probability.
Figure 4.
Figure 4.. Pathogenicity prediction of GABAA receptor β3 subunit, GABRB3.
(A) Positions of clinical missense variants are displayed in the three-dimensional structure of β3 subunit, built from 6HUK.pdb using PyMOL. According to ClinVar annotation, Class I pathogenic variants are colored in red, Class II uncertain variants in yellow, and Class III benign variants in green. (B) Pathogenicity prediction of saturating substitutions of GABRB3. Heat maps display the pathogenic probability of selected key regions. The top picture is from Rhapsody (RS) prediction, whereas the bottom picture is from AlphaMissense (AM) prediction. Wild type amino acids were colored in yellow for RS, and black for AM. (C) Correlation between Rhapsody and AlphaMissense prediction. Red dots represent pathogenic variants, yellow dots represent uncertain variants, and green dots represent benign variants according to ClinVar annotation. If no predictions are available in Rhapsody, such variants are artificially assigned a value of zero for Rhapsody probability.
Figure 5.
Figure 5.. Pathogenicity prediction of GABAA receptor γ2 subunit, GABRG2.
(A) Positions of clinical missense variants are displayed in the three-dimensional structure of γ2 subunit, built from 6X3S.pdb using PyMOL. According to ClinVar annotation, Class I pathogenic variants are colored in red, Class II uncertain variants in yellow, and Class III benign variants in green. (B) Pathogenicity prediction of saturating substitutions of GABRG2. Heat maps display the pathogenic probability of selected key regions. The top picture is from Rhapsody (RS) prediction, whereas the bottom picture is from AlphaMissense (AM) prediction. Wild type amino acids were colored in yellow for RS, and black for AM. (C) Correlation between Rhapsody and AlphaMissense prediction. Red dots represent pathogenic variants, yellow dots represent uncertain variants, and green dots represent benign variants according to ClinVar annotation. If no predictions are available in Rhapsody, such variants are artificially assigned a value of zero for Rhapsody probability.

Similar articles

References

    1. Wirrell E. C., Nabbout R., Scheffer I. E., Alsaadi T., Bogacz A., French J. A., Hirsch E., Jain S., Kaneko S., Riney K., Samia P., Snead O. C., Somerville E., Specchio N., Trinka E., Zuberi S. M., Balestrini S., Wiebe S., Cross J. H., Perucca E., Moshé S. L., Tinuper P., Epilepsia 2022, 63, 1333–1348. - PubMed
    1. Perucca P., Bahlo M., Berkovic S. F., Annual review of genomics and human genetics 2020, 21, 205–230. - PubMed
    1. Zhang M. W., Liang X. Y., Wang J., Gao L. D., Liao H. J., He Y. H., Yi Y. H., He N., Liao W. P., Seizure 2023, doi: 10.1016/j.seizure.2023.09.021. - DOI - PubMed
    1. Holmes G. L., Noebels J. L., Cold Spring Harbor perspectives in medicine 2016, 6, a028043. - PMC - PubMed
    1. Maljevic S., Møller R. S., Reid C. A., Pérez-Palma E., Lal D., May P., Lerche H., Curr Opin Neurol 2019, 32, 183–190; - PubMed
    2. XiangWei W., Jiang Y., Yuan H., Current opinion in physiology 2018, 2, 27–35. - PMC - PubMed

Publication types